Recent Resmed shows a gross margin of 61.1%, an operating margin of 33.4%, an EBITDA margin of 38.3%, and a net margin of 26.9%. Gross margin improved the most, by 1.7 percentage points, while net margin declined the most, by 0.3 percentage points.
Over the last 3 years, Resmed's margins averaged 58.69% gross, 30.95% operating, 34.93% EBITDA, and 24.86% net. All four current margins are above their three-year averages.
The strongest improvement was in gross margin, which increased by 1.7 percentage points, and operating margin also expanded by 0.7 percentage points and EBITDA margin also expanded by 1.1 percentage points, whereas net margin contracted by 0.3 percentage points.
Resmed recorded an average gross margin of 58.69% across the last 3 years. Resmed's current gross margin is 61.1% and is 2.4 percentage points above its three-year average. Looking back over the last 3 years, Resmed's gross margin reached 61.6% at its highest point in Mar 2026 and 55.1% at its lowest in Dec 2023.
Across the last 3 years, Resmed had an average operating margin of 30.95%. Resmed's current operating margin is 33.4% and is 2.5 percentage points above its three-year average. Looking back over the last 3 years, Resmed's operating margin reached 34.2% at its highest point in Mar 2026 and 25.3% at its lowest in Dec 2023.
Over the last 3 years, Resmed's EBITDA margin averaged 34.93%. The current EBITDA margin of 38.3% is 3.4 percentage points above its three-year average. During this period, EBITDA margin reached a high of 38.6% in Mar 2026 and a low of 29.4% in Dec 2023.
In the last 3 years, Resmed had an average net margin of 24.86%. Currently, Resmed's current net margin is 26.9%, which is 2 percentage points above its three-year average. Looking back over the last 3 years, Resmed's net margin reached 27.5% at its highest point in Dec 2025 and 19.8% at its lowest in Dec 2023.
With a gross margin of 61.1%, RMD is above the industry and its peers average but below the Healthcare sector average. Compared to its Healthcare sector average of 68.4%, Resmed's gross margin is 11% lower.
As of Jun 30, 2026, RMD has a gross margin of 61.1%.
The current operating margin for RMD is 33.4% as of Jun 30, 2026.
For the period ending Jun 30, 2026, RMD recorded an EBITDA margin of 38.3%.
For the period ending Jun 30, 2026, RMD recorded a net margin of 26.9%.
Over the past 3 years, RMD reported average margins of 58.7% gross, 31.0% operating, 34.9% EBITDA, and 24.9% net.
Over this 5-year history, RMD peaked at 61.6% gross in Mar 2026, 34.2% operating in Mar 2026, 38.6% EBITDA in Mar 2026, and 27.5% net in Dec 2025.
Resmed's lowest recorded margins during the past 5 years were 55.1% gross in Dec 2023, 25.3% operating in Dec 2023, 29.4% EBITDA in Dec 2023, and 15.2% net in Dec 2021.